Alkylphospholipids reversibly open epithelial tight junctions

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 27-32

  Leroy, Ancy ^a   De Bruyne, Georges K P ^a   Oomen, Lauran C J M ^b   Mareel, Marc M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Alkylphospholipids; Paracellular permeability; T84 colon cancer cells; Tight junctions

Indexed keywords

METHYL BETA CYCLODEXTRIN; PHOSPHOLIPID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INVASION; CELL COMPARTMENTALIZATION; CELL MEMBRANE PERMEABILITY; COLON CANCER; CONFOCAL LASER MICROSCOPY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; SOLUBILITY; TEMPERATURE DEPENDENCE; TIGHT JUNCTION;

ANTINEOPLASTIC AGENTS; BETA-CYCLODEXTRINS; BLOTTING, WESTERN; CELL MEMBRANE; CHOLESTEROL; COLONIC NEOPLASMS; CYCLODEXTRINS; DETERGENTS; EPITHELIAL CELLS; HUMANS; MANNITOL; MICROSCOPY, CONFOCAL; PHOSPHOLIPID ETHERS; PHOSPHORYLCHOLINE; PRECIPITIN TESTS; TIGHT JUNCTIONS; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0037231177     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lohmeyer M and Bittman R: Antitumor ether lipids and alkylphosphocholines. Drugs Fut 19: 1021-1037, 1994.
2. Hilgard P, Stekar J, Vögeli R, Engel J, Schumacher W, Eibl H, Unger C and Berger MR: Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). Eur J Cancer Clin Oncol 24: 1457-1461, 1988.
3. Fleer EAM, Unger C, Kim DJ and Eibl H: Metabolism of ether phospholipids and analogs in neoplastic cells. Lipids 22: 856-861, 1987.
4. Arthur G and Bittman R: The inhibition of cell signaling pathways by antitumor ether lipids. Biochim Biophys Acta 1390: 85-102, 1998.
5. Steelant WFA, Goeman JL, Philippé J, Oomen LCJM, Hilkens J, Krzewinski-Recchi M-A, Huet G, Van der Eycken J, Delannoy P, Bruyneel EA and Mareel MM: The alkyl-lysophospholipid 1-Ooctadecyl-2-O-methyl-glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro. Int J Cancer 92: 527-536, 2001.
6. Zahraoui A, Louvard D and Galli T: Tight junction, a platform for trafficking and signaling protein complexes. J Cell Biol 151: F31-F36, 2000.
7. Gumbiner B and Simons K: A functional assay for proteins involved in establishing an epithelial occluding barrier: identification of a Uvomorulin-like polypeptide. J Cell Biol 102: 457-468, 1986.
8. Tsukita S and Furuse M: Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol 9: 268-273, 1999.
9. Francis SA, Kelly JM, McCormack J, Rogers RA, Lai J, Schneeberger EE and Lynch RD: Rapid reduction of MDCK cell cholesterol by methyl-β-cyclodextrin alters steady state transepithelial electrical resistance. Eur J Cell Biol 78: 473-484, 1999.
10. Liu D-Z, Morris-Natschke SL, Kucera LS, Ishaq KS and Thakker DR: Structure-activity relationships for enhancement of paracellular permeability, by 2-alkoxy-3-alkylamidopropylphosphocholines across Caco-2 cell monolayers. J Pharm Sci 88: 1169-1174, 1999.
11. Jiang WG, Bryce BP, Horrobin DF and Mansel RE: Regulation of tight junction permeability, and occludin expression by polyunsaturated fatty, acids. Biochem Biophys Res Commun 244: 414-420, 1998.
12. Hecht G, Koutsouris A, Pothoulakis C, LaMont JT and Madara JL: Clostridium difficite toxin B disrupts the barrier function of T84 monolayers. Gastroenterology 102: 416-423, 1992.
13. Leroy A, Lauwaet T, De Bruyne G, Cornelissen M and Mareel M: Entamoeba histolytica disturbs the tight junction complex in human enteric T84 cell layers. FASEB J 14: 1139-1146, 2000.
14. Madara JL, Barenberg D and Carlson S: Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J Cell Biol 102: 2125-2136, 1986.
15. Shin J-S, Gao Z and Abraham SN: Involvement of cellular caveolae in bacterial entry into mast cells. Science 289: 785-788, 2000.
16. Scheiffele P, Roth MG and Simons K: Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J 16: 5501-5508, 1997.
17. Hakomori S-I: Glycosphingolipd microdomain (or "glycosignaling domain") of plasma membrane that mediates cell adhesion, coupled with signal transduction. In: Sialobiology and Other Novel Forms of Glycosylation (Inoue Y, Lee YC and Troy FA, eds) Gakushin Publishing Co, Osaka, Japan, 1999, pp. 217-226.
18. Nusrat A, Parkos CA, Verkade P, Foley CS, Liang TW, InnisWhitehouse W, Eastburn KK and Madara JL: Tight junctions are membrane microdomains. J Cell Sci 113: 1771-1781, 2000.
19. Yamamoto N and Ngwenya BZ: Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids. Cancer Res 47: 2008-2013, 1987.
20. Liu D-Z, LeCluyse EL and Thakker DR: Dodecylphosphocholinemediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers. J Pharm Sci 88: 1161-1168, 1999.
21. Furuse M, Furuse K, Sasaki H and Tsukita S: Conversion of zonutae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153: 263-272, 2001.
22. 1 epithelia. Am J Physiol 275: C544-C554, 1998.
23. Turner JR, Angle JM, Black ED, Joyal JL, Sacks DB and Madara JL: PKC-dependent regulation of transepithelial resistance: roles of MLC and MLC kinase. Am J Physiol 277: C554-C562, 1999.
24. 3 by HL-60 cells during induction of differentiation by dimethylsulfoxide. Leuk Res 17: 143-148, 1993.
25. Storch J and Munder PG: Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells. Lipids 22: 813-819, 1987.
26. Kotelevets L, Noë V, Bruyneel E, Myssiakine E, Chastre E, Mareel M and Gespach C: Inhibition by platelet-activating factor of Src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol-3′-kinase is a critical mediator of tumor invasion. J Biol Chem 273: 14138-14145, 1998.
27. Dive C, Watson JV and Workman P: Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells. Cancer Res 51: 799-806, 1991.
28. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka and Tsukita S: Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 137: 1393-1401, 1997.
29. Wong V: Phosphorylation of occludin correlates with occludin localization and function at the tight junction. Am J Physiol 273: C1859-C1867, 1997.
30. Farshori P and Kachar B: Redistribution and phosphorylation of occludin during opening and resealing of tight junctions in cultured epithelial cells. J Membr Biol 170: 147-156, 1999.